BackPURE Bioscience Overview

PURE Bioscience EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PURE.

Quarterly EBIT

-$684.00K
6.04% YoY

As of Jan 31, 2026

Annual EBIT (TTM)

-$1.80M
37.5% YoY

Trailing 12 months ending Jan 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)